Am. J. Respir. Crit. Care Med., Vol 154, No. 1, 07 1996, 6-17.
Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations
JW Smoller, MH Pollack, MW Otto, JF Rosenbaum and RL Kradin
McLean Hospital, Belmont, Massachusetts, USA.
There is intriguing evidence suggesting pathophysiologic relationships
among dyspnea, hyperventilation, and panic anxiety. The symptoms of panic
attacks and pulmonary disease overlap, so that panic anxiety can reflect
underlying cardiopulmonary disease and dyspnea can reflect an underlying
anxiety disorder. The pathogenesis of panic may be related to respiratory
physiology by several mechanisms: the anxiogenic effects of
hyperventilation, the catastrophic misinterpretation of respiratory
symptoms, and/or a neurobiologic sensitivity to CO2, lactate, or other
signals of suffocation. In a subset of patients with PD, incipient
pulmonary dysfunction may also contribute to their anxiety symptoms.
Patients with pulmonary disease, particularly those with obstructive lung
disease, have a high rate of panic symptoms and PD. There is reason to
believe that pulmonary disease constitutes a risk factor for the
development of panic related to repeated experiences with dyspnea and
life-threatening exacerbations of pulmonary dysfunction, repeated episodes
of hypercapnia or hyperventilation, the use of anxiogenic medications, and
the stress of coping with chronic disease. Panic in pulmonary patients may
carry significant morbidity, including phobic avoidance of activity, overly
aggressive treatment with anxiogenic medications, and more prolonged and
frequent hospitalization. Successful treatment of panic in these patients
can improve functional status and quality of life by relieving anxiety and
dyspnea. Nonpharmacologic treatment of panic, including
cognitive-behavioral approaches, can be useful in patients with concomitant
respiratory disease. Sedating medications such as benzodiazepines should be
used with caution in patients with pulmonary disease to avoid respiratory
depression. Serotonergic antidepressants (SSRIs) and anxiolytics
(buspirone) may be effective treatments for panic or generalized anxiety in
pulmonary patients and have relatively little potential for significant
adverse effects.
This article has been cited by other articles:

|
 |

|
 |
 
N. Livermore, J. E. Butler, L. Sharpe, R. A. McBain, S. C. Gandevia, and D. K. McKenzie
Panic Attacks and Perception of Inspiratory Resistive Loads in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
July 1, 2008;
178(1):
7 - 12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Han, Y. Zhu, S. Li, J. Zhang, X. Cheng, O. Van den Bergh, and K. P. Van de Woestijne
The Language of Medically Unexplained Dyspnea
Chest,
April 1, 2008;
133(4):
961 - 968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hill, R. Geist, R. S. Goldstein, and Y. Lacasse
Anxiety and depression in end-stage COPD
Eur. Respir. J.,
March 1, 2008;
31(3):
667 - 677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J-M. Boles, J. Bion, A. Connors, M. Herridge, B. Marsh, C. Melot, R. Pearl, H. Silverman, M. Stanchina, A. Vieillard-Baron, et al.
Weaning from mechanical ventilation
Eur. Respir. J.,
May 1, 2007;
29(5):
1033 - 1056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. M. Ross, T. M. A. Davis, and D. Y. Hogg
Screening and Assessing Adolescent Asthmatics for Anxiety Disorders
Clin Nurs Res,
February 1, 2007;
16(1):
5 - 24.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ramasamy, T. Hildebrandt, E. O'Hea, M. Patel, L. Clemow, R. Freudenberger, and C. Skotzko
Psychological and Social Factors That Correlate With Dyspnea in Heart Failure
Psychosomatics,
October 1, 2006;
47(5):
430 - 434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lowe, K. Grafe, C. Ufer, K. Kroenke, E. Grunig, W. Herzog, and M. M. Borst
Anxiety and Depression in Patients With Pulmonary Hypertension
Psychosom Med,
November 1, 2004;
66(6):
831 - 836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. I. Parekh, J. A. Blumenthal, M. A. Babyak, K. Merrill, R. M. Carney, R. D. Davis, and S. M. Palmer
Psychiatric Disorder and Quality of Life in Patients Awaiting Lung Transplantation
Chest,
November 1, 2003;
124(5):
1682 - 1688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Smoller, M. H. Pollack, S. Wassertheil-Smoller, B. Barton, S. L. Hendrix, R. D. Jackson, T. Dicken, A. Oberman, and D. S. Sheps
Prevalence and Correlates of Panic Attacks in Postmenopausal Women: Results From an Ancillary Study to the Women's Health Initiative
Arch Intern Med,
September 22, 2003;
163(17):
2041 - 2050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Luce and J. A. Luce
Management of Dyspnea in Patients With Far-Advanced Lung Disease: "Once I Lose It, It's Kind of Hard to Catch It . . . "
JAMA,
March 14, 2001;
285(10):
1331 - 1337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L P. Malmberg, K. Tamminen, and A. R A Sovijärvi
Orthostatic increase of respiratory gas exchange in hyperventilation syndrome
Thorax,
April 1, 2000;
55(4):
295 - 301.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. G. Colt, A. Powers, and T. G. Shanks
Effect of Music on State Anxiety Scores in Patients Undergoing Fiberoptic Bronchoscopy
Chest,
September 1, 1999;
116(3):
819 - 824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Woodman, L. J. Geist, S. Vance, C. Laxson, K. Jones, and J. N. Kline
Psychiatric Disorders and Survival After Lung Transplantation
Psychosomatics,
August 1, 1999;
40(4):
293 - 297.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. B. Stein, K. L. Jang, and W. J. Livesley
Heritability of Anxiety Sensitivity: A Twin Study
Am J Psychiatry,
February 1, 1999;
156(2):
246 - 251.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Meek
Dyspnea . Mechanisms, Assessment, and Management: A Consensus Statement
Am. J. Respir. Crit. Care Med.,
January 1, 1999;
159(1):
321 - 340.
[Full Text]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|